A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Montefiore Medical Center
Mayo Clinic
OHSU Knight Cancer Institute
NRG Oncology
NRG Oncology
University of Washington
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
University Hospital Heidelberg
University of Florida
University Hospital Heidelberg
University Hospital Heidelberg
Jonsson Comprehensive Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center
NRG Oncology
Massachusetts General Hospital
Mayo Clinic
University of Oklahoma
Emory University
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
University of Washington
Mayo Clinic
University of Michigan Rogel Cancer Center
City of Hope Medical Center
Chang Gung Memorial Hospital
Loma Linda University
Mayo Clinic